Loading provider…
Loading provider…
Ophthalmology Physician in Redding, CA
NPI: 1255326476Primary Employer
SHASTA EYE MEDICAL GROUP INC
HQ Phone
Get MD Bruce's Phone Numberphone_androidMobile
Get MD Bruce's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2027
FL State Medical License
1992 - 1998

American Board of Ophthalmology
Ophthalmology
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1991
University of Miami/Jackson Health System/Bascom Palmer Eye Institute
Residency • Ophthalmology
1992 - 1995
Sutter Health/California Pacific Medical Center
Internship • Internal Medicine
1991 - 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 1,283 | 1,535 |
| 2 | 92134Diagnostic imaging of retina | 955 | 2,610 |
| 3 | 92012Eye and medical examination for diagnosis and treatment, established patient | 512 | 838 |
| 4 | 92250Photography of the retina | 510 | 860 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 490 | 549 |
Authors: DeLeon, Jesse, Silverstein, Bruce E, Allaire, Catherine, Gearinger, Lynne S, Bateman, Kirk M, Morris, Timothy W, Comstock, Timothy L
Journal: Clin Drug Investig
Authors: Silverstein, Bruce E, Allaire, Catherine, Bateman, Kirk M, Gearinger, Lynne S, Morris, Timothy W, Comstock, Timothy L
Journal: Clin Ther
Lead Sponsor: CORD, LLC
Intervention / Treatment: DEVICE: Model SC9, DEVICE: Model LI61SE
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 Ophthalmic Suspension dosed BID, DRUG: KPI-121 1% Ophthalmic Suspension dosed BID